Nieddu F, Vignoli M, Ferraro E, Boscia S, et al. Public health impact of nirsevimab and reduction of RSV hospitalisation in all infants: early real-world data from Tuscany (Italy) in the 2024-25 RSV season. Eur J Pediatr 2025;184:728.
PMID: 41182397